Hancheng Cai, Ph.D.

Hancheng Cai, PhD, is a radiochemist and molecular imaging scientist. My clinical work focus on FDA cGMP PET drug production facility implementation and operation. Briefly, Dr. Cai oversees all the clinical production of PET tracers at Mayo Clinic Florida, leads a team to produce FDA-approved PET drugs for daily clinical use, and investigational tracers (F-18/C-11 labeled compounds as INDs) for PET imaging of cancer cardiovascular disease, and neurological disorders in human.

Dr. Cai's research aims to developing novel radiopharmaceuticals for the imaging and therapy of cancer, neurological disorders, and cardiovascular diseases from preclinical discovery to clinical investigation. Specifically, his research work focus on development novel radiopharmaceuticals for PET imaging of cancer biology/metabolism, immunotherapy, inflammation, and neurological disorders.